Business, energy, technology, markets and global industry news from Business News Today

PROTECT

PharmaDeviceNews PROTECT
Representative image of a clinician reviewing kidney cancer scans, reflecting Merck & Co., Inc.’s FDA approval of Keytruda and Welireg combinations for adjuvant clear cell renal cell carcinoma treatment.
Pharma & Biotech

Travere Therapeutics FILSPARI shows sustained biomarker reductions in Phase 3 PROTECT study

Travere's FILSPARI reduced four IgA nephropathy biomarkers in new PROTECT data, adding evidence on kidney protection without proving disease modification.

Read More
Representative image: A pediatric diabetes specialist reviews glucose data during an infusion visit as Sanofi’s Tzield expands into newly diagnosed stage 3 type 1 diabetes care.
Pharma & Biotech

Why Sanofi’s Tzield expansion changes the treatment window for type 1 diabetes

Discover how Sanofi’s Tzield approval could reshape newly diagnosed pediatric type 1 diabetes care and why major clinical questions remain.

Read More